Skip to main content
OpenTrials
Recruiting

NCT Number: NCT07312487

Inadequate Analgesia During Cesarean Section Under Spinal Anesthesia

Inadequate analgesia during cesarean section is a common condition, notably addressed by national recommendations from the SFAR (French Society of Anesthesia and Intensive Care) in 2021.

The objective of this study is to identify the specific characteristics of this condition in Strasbourg in terms of risk factors and management, and then to propose a protocol for its prevention and management.

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year–40 year

Sex eligibility

Female

Study type

Observational

Primary location

Service d'Anesthésie Réanimation médecine Péri-Opératoire - Hôpitaux Universitaires de Strasbourg

Strasbourg, 67091, France

Location status: Recruiting

Location contact

Arthur APPELSHAUSER, MD

PRINCIPAL_INVESTIGATOR

Stefanie KOESSLER, MD

CONTACT

[email protected]

33 3 88 12 70 90

Stefanie KOESSLER, MD

PRINCIPAL_INVESTIGATOR

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Adult woman (age ≥18 years)
  • Giving birth by cesarean section between January 1, 2021, and December 31, 2022, at the Strasbourg University Hospital

Exclusion criteria

  • Patient who has expressed her opposition to the reuse of her data for scientific research purposes.

Treatment and study plan

Primary outcomes

  1. General anesthesia rates

    Time frame: at day 1 post-operative

Study contacts

Contact information is provided by the study sponsor or research team.

Stefanie KOESSLER, MD

CONTACT

[email protected]

33 3 88 12 70 90

Sponsors and collaborators

Lead sponsor

University Hospital, Strasbourg, France

Other

Registry information

Official study title

Incidence, Associated Factors, and Management of Inadequate Analgesia During Cesarean Section Under Spinal Anesthesia in the Maternity Wards of the Strasbourg University Hospital: a 2-year Retrospective Study

Acronym: ALGOCESA

Important dates

Study start
2024
Primary completion
2026
Study completion
2026
First posted
Dec 31, 2025
Registry last updated
Dec 31, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.